End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
179,100.00 KRW | -0.78% | -0.89% | -4.48% |
Sales 2023 by Business Segment
Sales 2023 by Geography
Historical Breakdown of Revenue by Business Segments
Operating Income: Breakdown by Business Segment
Fiscal Period: December | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|---|---|
Biological Products | ||||||||||
Bio Medical Supply | 982B | 1,690B | 1,616B | 1,937B | 1,873B | |||||
D&A | 145B | 163B | 174B | 175B | 195B | |||||
Operating Income | 360B | 703B | 712B | 618B | 638B | |||||
Pharmaceutical Products | ||||||||||
Chemical Drugs | 173B | 242B | 557B | 654B | 501B | |||||
D&A | 13.63B | 16.49B | 46.13B | 51.1B | 53.81B | |||||
Operating Income | 15.33B | 8.53B | 57.49B | 34.61B | 27.86B | |||||
Other | 4.27B | 2.63B | 3.05B | 3.88B | 5.14B | |||||
D&A | 520M | 277M | 281M | 297M | 240M | |||||
Operating Income | -1.12B | 211M | 224M | 294M | 454M | |||||
Intersectoral Insider Transaction Reconciliation | -30.36B | -85.76B | -264B | -311B | -203B | |||||
D&A | -372M | -328M | -320M | -304M | -3.1B | |||||
Operating Income | 4.06B | 599M | -17.06B | -5.3B | -15.2B |
Geographical Revenue Distribution History
Fiscal Period: December | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|---|---|
South Korea | 1,017B | 1,542B | 2,015B | 2,324B | 2,262B | |||||
Total Assets | - | - | 2,160B | 2,341B | 14,258B | |||||
Interest Expense | - | - | - | - | - | |||||
Income Tax Expense | - | - | - | - | - | |||||
D&A | - | - | - | - | - | |||||
CAPEX | - | - | - | - | - | |||||
Net Income | - | - | - | - | - | |||||
EBT | - | - | - | - | - | |||||
Americas | - | - | 84.61B | 131B | 117B | |||||
Total Assets | - | - | 209M | - | - | |||||
Asia | - | - | 76.42B | 140B | - | |||||
Total Assets | - | - | 308B | 300B | 117B | |||||
Foreign | 111B | 308B | - | - | - | |||||
Consolidation Adjustment | - | - | -264B | -311B | -203B | |||||
Total Assets | - | - | -5.98B | -11.1B | -22.06B | |||||
Total Assets | - | - | - | - | 185B | |||||
Total Assets | - | - | - | - | 3.48B | |||||
Total Assets | - | - | - | - | 1.72B | |||||
Total Assets | - | - | - | - | 7.91B |
- Stock Market
- Equities
- A068270 Stock
- Financials Celltrion, Inc.
- Business Segments